Worth reading
62In focus
Scored from 5 of 6 sectionsDirection
Mixed performance
Direction inferred from the company’s description.Scale
78448
¥ millionWording
Conditional
How definitive the wording is.Results for this period
Full year1 April 2025–31 March 2026ConsolidatedJapanese GAAPNet Sales738,243¥ millionYear on year -4.6%Progress 87.9%
Operating profit45,293¥ millionYear on year -10.9%Progress 76.8%
Ordinary income51,947¥ millionYear on year -13.9%Progress 78.7%
Net income attributable to owners of the parent-40,318¥ million
The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
Net income per share-¥207.04
Operating Margin6.1%
Financial position at period-end
Total assets1,113,040¥ million
of which net assets 679,550 ¥ millionEquity ratio 58.1%vs. prior year-end -1.6pt
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Cash inflows and outflows
Operating+74,726
Investment-61,311
Financials-14,364
Net change-949
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ million).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
Cash and cash equivalents at end of period¥59,096 million
Segment revenueGreen Energy & Chemicals 2,869 Hundreds of millions of yen (YoY -11.2%), Functional Chemicals 4,483 Hundreds of millions of yen (YoY +0.9%)
Segment profitGreen Energy & Chemicals ¥38 100 million (ordinary income) (YoY -81.2%), Functional Chemicals ¥491 100 million (ordinary income) (YoY +11.8%)
Regional sales¥234,847 million, ¥146,541 million, ¥233,711 million, ¥48,322 million, ¥74,820 million
Outlook and shareholder returns
Full-year earnings forecast
Net Sales¥840,000 million (YoY +13.8%)
Operating profit¥59,000 million (YoY +30.3%)
Ordinary income¥66,000 million (YoY +27.1%)
Net income¥46,000 million
Annual Dividend Forecast¥100 per share → ¥110 per share（+10.0%）
Payout ratioFiscal year ending March 2026 Not disclosed / Fiscal year ending March 2027 (forecast) 46.6%
Shareholder Return PolicyThe company targets a total payout ratio of 50% as a medium-term guideline for shareholder returns and has adopted a progressive dividend policy. It targets a dividend amount equivalent to a 3.0% DOE over the medium term.
Factors Behind Changes in Business Performance
Revenue declined despite strong sales of electronic materials, due to declining market conditions for engineering plastics and methanol and the withdrawal from the ortho-xylene chain business. Operating income declined due to lower market conditions, intensifying competition in meta-xylenediamine and its derivatives, and higher fixed costs associated with increased production capacity at the Taiwan site. Ordinary income declined due to deterioration in the share of profit or loss of equity-method affiliates, while profit attributable to owners of the parent declined and the company reported a net loss due to the recognition of impairment losses on fixed assets in multiple businesses, among other factors.
Disclosure regarding the going concern assumption
Not applicable.
Change in accounting policy
基準改正に伴う変更 Noそれ以外の変更 No見積りの変更 No修正再表示 No
Changes in the scope of consolidation0 additions and 0 exclusions (no material change in the scope of consolidation during the period)
Material subsequent eventsNot applicable.
Impairment loss¥78,448 million. The impairment losses related to fixed assets and were recognized for a methanol producer in Trinidad and Tobago, a meta-xylenediamine manufacturing subsidiary in the Netherlands, manufacturing subsidiaries in China and Taiwan, and the polycarbonate business.
Breakdown of extraordinary income (loss)Extraordinary income Gain on sale of non-current assets ¥9,022 million, Gain on sale of investment securities ¥4,927 million, Insurance proceeds received ¥511 million, Subsidy Income ¥268 million / Extraordinary loss Impairment Losses ¥78,448 million, Business structure improvement costs ¥1,809 million, Loss associated with the cancellation of construction work ¥1,045 million, Loss on damage compensation ¥659 million, Provision for allowance for doubtful accounts ¥595 million, Impairment Loss on Investment Securities ¥185 million
Depreciation and amortization¥38,242 million
Availability of Supplementary Financial Results MaterialsYes
Availability of Financial Results BriefingYes (for securities analysts and institutional investors)
Issued Shares at Period-End211,686,599 shares
Treasury Shares at Period-End16,945,105 shares
| Item | Details |
|---|---|
| Fiscal Period Classification | Full year |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 April 2025–31 March 2026 |
| Net Sales | ¥738,243 million (YoY -4.6%) |
| Operating profit | ¥45,293 million (YoY -10.9%) |
| Ordinary income | ¥51,947 million (YoY -13.9%) |
| Profit attributable to owners of the parent | ¥-40,318 million |
| Net income per share | -¥207.04 |
| Operating Margin | 6.1% |
| Equity ratio | End of the current fiscal period 58.1% / End of previous period 59.7% |
| Total assets | ¥1,113,040 million |
| Net assets | ¥679,550 million |
| Cash flows from operating activities | ¥74,726 million |
| Cash flows from investing activities | ¥-61,311 million |
| Cash flows from financing activities | ¥-14,364 million |
| Cash and cash equivalents at end of period | ¥59,096 million |
| Full-year earnings forecast | Net Sales ¥840,000 million (YoY +13.8%) / Operating profit ¥59,000 million (YoY +30.3%) / Ordinary income ¥66,000 million (YoY +27.1%) / Net income ¥46,000 million |
| Annual Dividend Forecast | ¥100 per share → ¥110 per share（+10.0%） |
| Payout ratio | Fiscal year ending March 2026 Not disclosed / Fiscal year ending March 2027 (forecast) 46.6% |
| Shareholder Return Policy | The company targets a total payout ratio of 50% as a medium-term guideline for shareholder returns and has adopted a progressive dividend policy. It targets a dividend amount equivalent to a 3.0% DOE over the medium term. |
| Segment revenue | Green Energy & Chemicals 2,869 Hundreds of millions of yen (YoY -11.2%), Functional Chemicals 4,483 Hundreds of millions of yen (YoY +0.9%) |
| Segment profit | Green Energy & Chemicals ¥38 100 million (ordinary income) (YoY -81.2%), Functional Chemicals ¥491 100 million (ordinary income) (YoY +11.8%) |
| Regional sales | ¥234,847 million, ¥146,541 million, ¥233,711 million, ¥48,322 million, ¥74,820 million |
| Depreciation and amortization | ¥38,242 million |
| Impairment loss | ¥78,448 million. The impairment losses related to fixed assets and were recognized for a methanol producer in Trinidad and Tobago, a meta-xylenediamine manufacturing subsidiary in the Netherlands, manufacturing subsidiaries in China and Taiwan, and the polycarbonate business. |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on sale of non-current assets ¥9,022 million, Gain on sale of investment securities ¥4,927 million, Insurance proceeds received ¥511 million, Subsidy Income ¥268 million / Extraordinary loss Impairment Losses ¥78,448 million, Business structure improvement costs ¥1,809 million, Loss associated with the cancellation of construction work ¥1,045 million, Loss on damage compensation ¥659 million, Provision for allowance for doubtful accounts ¥595 million, Impairment Loss on Investment Securities ¥185 million |
| Disclosure regarding the going concern assumption | Not applicable. |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | 0 additions and 0 exclusions (no material change in the scope of consolidation during the period) |
| Material subsequent events | Not applicable. |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Yes (for securities analysts and institutional investors) |
| Issued Shares at Period-End | 211,686,599 shares |
| Treasury Shares at Period-End | 16,945,105 shares |
| Factors Behind Changes in Business Performance | Revenue declined despite strong sales of electronic materials, due to declining market conditions for engineering plastics and methanol and the withdrawal from the ortho-xylene chain business. Operating income declined due to lower market conditions, intensifying competition in meta-xylenediamine and its derivatives, and higher fixed costs associated with increased production capacity at the Taiwan site. Ordinary income declined due to deterioration in the share of profit or loss of equity-method affiliates, while profit attributable to owners of the parent declined and the company reported a net loss due to the recognition of impairment losses on fixed assets in multiple businesses, among other factors. |
Items this document does not state (2)
Revision to Earnings ForecastOrders received and order backlog
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Declining market conditions for engineering plastics and methanol, withdrawal from the ortho-xylene chain business, intensifying competition in meta-xylenediamine and its derivatives, higher fixed costs associated with increased production capacity at the Taiwan site, and the recognition of impairment losses on fixed assets in multiple businesses.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.